Pathological recognition of diffuse malignant mesothelioma of the pleura: the significance of the historical perspective as regards this signal tumor

Seminars in Diagnostic Pathology

Volumn 23, Issue 1, 2006, Pages 25-34

  Mark, Eugene J ^a   Kradin, Richard L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Asbestos; Diffuse malignant mesothelioma; History

Indexed keywords

ASBESTOS;

ARTICLE; ASBESTOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CHEMICAL CARCINOGENESIS; ENVIRONMENTAL EXPOSURE; GEOLOGY; HISTOPATHOLOGY; HISTORY OF MEDICINE; HUMAN; INFORMATION RETRIEVAL; LUNG CARCINOGENESIS; LUNG TOXICITY; MALIGNANT MESOTHELIOMA; MEDICAL DOCUMENTATION; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; TISSUE SECTION;

ASBESTOS; CARCINOGENS; HISTORY, 15TH CENTURY; HISTORY, 16TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, ANCIENT; HISTORY, MEDIEVAL; HUMANS; INCIDENCE; MESOTHELIOMA; PLEURAL NEOPLASMS; PORTRAITS;

EID: 33748773380     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semdp.2006.06.004     Document Type: Article

References (40)

1. Mark E.J., and Yokoi T. Absence of evidence for a significant background incidence of diffuse malignant mesothelioma apart from asbestos exposure. Ann N Y Acad Sci 643 (1991) 196-204
2. Driscoll T., Nelson D., Steenland K., et al. The global burden of disease due to occupational carcinogens. Am J Ind Med 48 (2005) 419-431
3. Nelson D., Concha-Barrientos M., Driscoll T., et al. The global burden of seleced occupational diseases and injury risks: methodology and summary. Am J Ind Med 48 (2005) 400-418
4. Landrigan P.J., and Kazemi H. The third wave of asbestos disease: exposure to asbestos in place. Public health control. Part 13: Mesothelioma, a "Signal Tumor.". Ann NY Acad Sci 643 (1991) 449-458
5. Report on Carcinogens. (ed 10). (2002), U.S. Department of Health and Human Services, Technology Planning and Management Corporation, Durham, NC 111-119
6. Hillerdal G. Mesothelioma: cases associated with non-occupational and low dose exposures. Occup Environ Med 56 (1999) 505-513
7. Puntoni R., Cerrano P.G., and Filiberti R. Molecular epidemiology of mesothelioma. In: Pass H.I., Vogelzang N.J., and Carbone M. (Eds). Malignant Mesothelioma. Advances in Pathogenesis, Diagnosis, and Translational Therapies (2005), Springer Science and Business Media, New York, NY 225-241
8. Chahinian A.P. Clinical presentation and natural history of mesothelioma: pleural and pericardial. In: Pass H.I., Vogelzang N.J., and Carbone M. (Eds). Malignant Mesothelioma. Advances in Pathogenesis, Diagnosis, and Translational Therapies (2005), Springer Science and Business Media, New York, NY 380-390
9. Peto J., Decarli A., La Vecchia C., et al. The European mesothelioma epidemic. Br J Cancer 79 (2002) 666-672
10. Wolf K.M., Piotrowski Z.H., Engel J.D., et al. Malignant mesothelioma with occupational and environmental asbestos exposure in an Illinois community hospital. Arch Intern Med 147 (1987) 2145-2149
11. Nam J., Rice C., and Gail M.H. Comparison of asbestos exposure assessments by next-of-kin respondents, by an occupationsl hygienist, and by a job-exposure matrix from the National Occupational Hazard Survey. Am J Ind Med 47 (2005) 443-450
12. Leichner F. Primärer Deckzellentumor des Bauchfells bei Asbestose. Archiv Gewerbepathologie Gewerbehygiene 13 (1954) 382-392
13. Welch L.S., Acherman Y.I.Z., Haile E., et al. Asbestos and peritoneal mesothelioma among college-educated men. Int J Occup Environ Health 11 (2005) 254-258
14. Selikoff I.J., and Lee D.H.K. Asbestos and Disease: Historical Background (Chapter 1) (1970), Academic Press, New York, NY 3-32
15. Landrigan P.J., and Kazemi H. The Third Wave of Asbestos Disease: Exposure to Asbestos in Place. Public Health Control. Ann NY Acad Sci Volume 643 (1991)
16. Fischer W. Die Gewächse der Lunge und des Brustfells. In: Henke F., and Lubarsch O. (Eds). Handbuch der speziellen pathologischen Anatomie und Hisologie (1931), Julius Springer, Berlin 509-606
17. Fischer-Wasels B. s̈ber die primären malignen Geschwüulste der Serosadeckzellen. Zeitschrft Krebsforschung 37 (1932) 21-29
18. Wedler H.W. Uber den Lungenkrebs bei Asbestose. Deutsch Archiv Klin Med 191 (1943) 189-209
19. Walther H.E. Krebsmetastasen (1948), Benno Schwabe & Co, Basel 137-146
20. Case Records of the Massachusetts General Hospital. Case 33111. N Engl J Med 236 (1947) 407-412
21. Clinico-Pathologic Conference. Chronic pleurisy and peritonitis. Am J Med 7 (1949) 396-406
22. Willis R.A. Pathology of Tumours. ed 3 (1960), Butterworths, London 186
23. Van der Schoot HCM: Asbestosis en pleuragezwellen. Ned Tijdschr Geneeskd 102 (1958) 1125
24. Wagner J.C., Sleggs C.A., and Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 17 (1960) 260-271
25. Selikoff I.J., Churg J., and Hammond E.C. Relation between exposure to asbestos and mesothelioma. N Engl J Med 272 (1965) 560-565
26. Hillerdal G. Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest 77 (1983) 321-343
27. Mancuso T.F. Mesothelioma among railroad workers in the United States. Ann NY Acad Sci 643 (1991) 333-346
28. Peterson J.T., Greenberg S.D., and Buffler P.A. Non-asbestos-related malignant mesothelioma. Cancer 54 (1984) 501-513
29. Baris Y.I., Artvinli M., and Sahin A.A. Environmental mesothelioma in Turkey. Ann NY Acad Sci 330 (1979) 423-432
30. Hill B. The environment and disease: association or causation?. Proc Roy Soc Med 58 (1965) 295-299
31. Klemperer P., and Rabin C.B. Primary neoplasms of the pleura. Arch Pathol 11 (1930) 385-412
32. Bogardus G.M., Knudtson K.P., and Mills W.H. Pleural mesothelioma; report of four cases. Am Rev Tuberc 71 (1955) 280-290
33. Tossavainen D. Global use of asbestos and the incidence of mesothelioma. Int J Occup Environ Health 10 (2004) 22-25
34. Peto J., Hodgson J.T., Matthews F.E., et al. Continuing increase in mesothelioma mortality in Britain. Lancet 345 (1995) 535-539
35. Leigh J., Davidson P., Hendrie L., et al. Malignant mesothelioma in Australia, 1945-2000. Am J Ind Med 41 (2002) 188-201
36. Murayama T., Takahashi K., Natori Y., et al. Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model. Am J Ind Med 49 (2006) 1-7
37. Price B., and Ware A. Mesothelioma trends in the United states: an update based on surveillance, epidemiology, and end results program data for 1973 through 2003. Am J Epidemiol 159 (2004) 107-112
38. Robinson B.W.S., and Lake R.A. Advances in malignant mesothelioma. N Engl J Med 353 (2005) 1591-1603
39. Ilgren E.B., and Wagner J.C. Background incidence of mesothelioma: animal and human evidence. Reg Toxicol Pharmacol 13 (1991) 133-149
40. Landrigan P.J., Lioy P.J., Thurston G., et al. Health and environmental consequences of the World Trade Center Disaster. Environ Health Perspect 112 (2004) 731-739